| Lactose (India) Ltd | 144 Cr. | 114 | 247/84.3 | 32.8 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.80 Cr. | 1.99 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 5,012 Cr. | 460 | 480/192 | 112 | 22.8 | 0.14 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 35.6 Cr. | 48.0 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 32.8 Cr. | 22.4 | 29.1/17.0 | 34.2 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 65.5 Cr. | 87.0 | 134/78.9 | 17.3 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 51,849 Cr. | 1,837 | 2,286/1,275 | 38.9 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 387 Cr. | 17.0 | 22.5/10.8 | 23.5 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 822 Cr. | 1,740 | 1,788/635 | 35.1 | 299 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 104 Cr. | 20.8 | 32.0/15.0 | 31.7 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 790 Cr. | 268 | 449/219 | 7.55 | 123 | 0.91 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 14.2 Cr. | 5.68 | 9.28/2.11 | 8.05 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 394 Cr. | 406 | 477/112 | 63.5 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,826 Cr. | 1,109 | 1,584/1,045 | 47.1 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 57.3 Cr. | 0.28 | 1.24/0.28 | 3.77 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 48.6 Cr. | 20.2 | 26.3/6.40 | 50.1 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 10.0 Cr. | 9.93 | 17.2/9.01 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 175 Cr. | 489 | 896/443 | 9.47 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 69.0 Cr. | 69.0 | 71.2/26.1 | 177 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,983 Cr. | 1,432 | 2,452/1,345 | 42.0 | 173 | 0.73 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 18.0 Cr. | 39.3 | 88.7/37.6 | 37.4 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 16.7 Cr. | 6.70 | 6.70/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.5 Cr. | 124 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 35.2 Cr. | 64.3 | 64.3/9.41 | 391 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.0 Cr. | 41.1 | 80.0/0.00 | 43.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.00 Cr. | 20.0 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 11,126 Cr. | 641 | 1,028/464 | 31.1 | 65.3 | 0.17 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 88.9 Cr. | 20.6 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.7 Cr. | 23.0 | 43.7/17.4 | 50.7 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 99,652 Cr. | 2,414 | 3,055/2,115 | 55.1 | 355 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 252 Cr. | 438 | 524/241 | 26.4 | 119 | 1.04 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 57.8 Cr. | 40.3 | 62.6/31.6 | 52.1 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 64,714 Cr. | 1,104 | 1,442/994 | 19.0 | 557 | 0.37 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 125 Cr. | 201 | 303/170 | 182 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 903 Cr. | 90.1 | 123/74.0 | 19.6 | 32.5 | 1.67 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 42.7 Cr. | 32.7 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,172 Cr. | 1,731 | 1,868/796 | 63.2 | 160 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.36 Cr. | 0.66 | 1.45/0.55 | 87.1 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 247 Cr. | 32.2 | 68.0/30.0 | 13.1 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.71 Cr. | 14.9 | 25.5/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 140 Cr. | 5.93 | 6.57/2.82 | 325 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 63,293 Cr. | 29,785 | 37,000/25,260 | 43.6 | 1,992 | 1.60 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,641 Cr. | 843 | 972/550 | 28.7 | 220 | 0.60 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 258 Cr. | 90.9 | 91.3/31.3 | 62.0 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,764 Cr. | 1,571 | 1,628/535 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,067 Cr. | 1,296 | 1,870/1,080 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 841 Cr. | 256 | 330/154 | 19.6 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 584 Cr. | 437 | 568/270 | 12.5 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,281 Cr. | 466 | 950/455 | 26.2 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,652 Cr. | 1,169 | 1,599/991 | 23.4 | 768 | 0.86 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,20,897 Cr. | 3,572 | 3,790/2,886 | 59.9 | 224 | 0.89 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,187 Cr. | 129 | 317/98.0 | | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,561 Cr. | 16.6 | 24.0/14.1 | 27.4 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 33,096 Cr. | 865 | 1,360/848 | 94.1 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,419 Cr. | 194 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,04,624 Cr. | 1,686 | 1,924/1,547 | 35.3 | 301 | 0.94 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,636 Cr. | 587 | 886/441 | 107 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,807 Cr. | 300 | 319/175 | 40.0 | 75.9 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 356 Cr. | 1,177 | 1,680/956 | 20.6 | 650 | 0.12 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,061 Cr. | 361 | 502/265 | 54.9 | 121 | 0.13 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,157 Cr. | 205 | 232/111 | 171 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,944 Cr. | 4,752 | 6,899/4,146 | 30.7 | 340 | 2.48 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,953 Cr. | 2,390 | 2,776/1,772 | 35.4 | 335 | 0.83 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 10,221 Cr. | 6,157 | 6,739/4,863 | 34.0 | 323 | 2.04 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 180 Cr. | 51.0 | 87.5/33.1 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 24,156 Cr. | 5,280 | 5,993/3,701 | 35.8 | 922 | 0.66 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 125 Cr. | 101 | 348/81.0 | 8.81 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,713 Cr. | 443 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,570 Cr. | 704 | 1,998/604 | 41.9 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,217 Cr. | 15,758 | 18,100/10,060 | 153 | 1,188 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 342 Cr. | 15.2 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,797 Cr. | 826 | 1,505/660 | 8.70 | 425 | 0.72 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,665 Cr. | 48.6 | 91.7/41.7 | 28.7 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,275 Cr. | 183 | 359/162 | 23.6 | 54.4 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 102 Cr. | 64.6 | 130/63.6 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 334 Cr. | 93.7 | 177/90.2 | 44.6 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 87,113 Cr. | 1,907 | 2,403/1,774 | 23.6 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,058 Cr. | 528 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 51,267 Cr. | 950 | 958/473 | 75.1 | 91.1 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 931 Cr. | 898 | 1,235/596 | 21.5 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 151 Cr. | 70.0 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 802 Cr. | 166 | 327/154 | 23.0 | 107 | 1.79 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 694 Cr. | 397 | 500/265 | 24.8 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,820 Cr. | 1,119 | 1,310/802 | 36.6 | 393 | 0.44 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,417 Cr. | 1,687 | 1,998/1,303 | 38.6 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,496 Cr. | 224 | 328/182 | 35.1 | 36.1 | 1.12 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 32,550 Cr. | 1,283 | 1,758/1,168 | 36.4 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,727 Cr. | 92.9 | 127/57.5 | 25.9 | 57.5 | 0.87 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 760 Cr. | 103 | 124/67.2 | 34.5 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,536 Cr. | 275 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,973 Cr. | 241 | 465/236 | 47.0 | 102 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,382 Cr. | 1,625 | 2,786/1,243 | 36.8 | 369 | 0.43 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,361 Cr. | 335 | 504/285 | 55.0 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,765 Cr. | 567 | 628/412 | 28.9 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 50,656 Cr. | 1,795 | 2,286/1,275 | 38.0 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 45,272 Cr. | 2,672 | 3,516/1,921 | 47.8 | 115 | 1.56 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 31,248 Cr. | 1,897 | 2,131/1,200 | 27.5 | 592 | 0.95 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 7,081 Cr. | 435 | 559/359 | 26.3 | 140 | 1.16 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,978 Cr. | 1,614 | 1,910/1,097 | 56.7 | 210 | 0.45 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,07,223 Cr. | 1,285 | 1,406/1,020 | 18.6 | 432 | 0.61 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,642 Cr. | 296 | 322/176 | 39.1 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,27,195 Cr. | 1,575 | 1,673/1,310 | 23.6 | 386 | 0.81 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 15,242 Cr. | 2,005 | 2,641/1,551 | 27.0 | 347 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 323 Cr. | 110 | 203/95.6 | 159 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,603 Cr. | 152 | 191/105 | 15.0 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 63.5 Cr. | 39.0 | 73.3/38.0 | 22.8 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 48,699 Cr. | 364 | 406/291 | 135 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,873 Cr. | 1,855 | 2,215/1,430 | 40.9 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 132 Cr. | 82.6 | 141/76.3 | 18.4 | 48.6 | 1.44 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 320 Cr. | 135 | 179/67.8 | 31.8 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 23,059 Cr. | 9,224 | 10,691/6,220 | 109 | 308 | 0.34 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,144 Cr. | 743 | 843/544 | 39.3 | 113 | 0.62 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 190 Cr. | 90.3 | 137/85.0 | 7.22 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 65,456 Cr. | 5,470 | 6,062/4,492 | 28.8 | 1,002 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,764 Cr. | 905 | 1,156/725 | 30.0 | 264 | 1.21 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 482 Cr. | 842 | 1,540/763 | 76.7 | 688 | 0.60 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 29,958 Cr. | 2,396 | 3,181/2,022 | 32.2 | 303 | 1.17 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,456 Cr. | 309 | 509/258 | 25.2 | 127 | 1.69 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,425 Cr. | 481 | 575/312 | 24.7 | 136 | 0.21 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,781.62 Cr | 1,180.92 | | 50.43 | 194.36 | 0.33% | 16.24% | 14.95% | 6.10 |